Corticosteroids Before Extubation in Critically Ill Children
Official title: Corticoïdes Avant Extubation en réanimation pédiatrique : étude Multicentrique, Prospective, randomisée, Contre Placebo
Run by Assistance Publique - Hôpitaux de Paris · NCT06722118 · Data updated 2026-11-12
This study tests whether giving dexamethasone before removing a breathing tube helps prevent airway problems in kids who are in the ICU and on a ventilator.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 2 Days to 6 Years |
| Sex | All |
| Enrollment | 348 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 15 sites (Bordeaux and 14 other locations) |
| Status | Recruiting |
| Started | October 28, 2025 |
| Main results expected | October 2028 |
| Study ends | November 2028 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT06722118 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 2 days to 6 years who have been intubated and on mechanical ventilation for at least 36 hours and are ready for planned extubation.
✕Probably not a fit
Children with contraindications to IV dexamethasone or those not meeting extubation readiness criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, multicenter, double‑blind study will compare intravenous dexamethasone given before extubation to placebo in children aged 2 days to 6 years who have been on mechanical ventilation for at least 36 hours. The goal is to see if pre‑extubation steroids reduce the incidence of respiratory distress due to upper airway obstruction after extubation. Participating centers include hospitals in Bordeaux, Lyon, and Garches. Key eligibility includes stable oxygenation, PEEP, and airway/cardiovascular status, with parental consent required. Outcomes will inform pediatric extubation practices in PICUs where steroid use is not yet standard.
Why it matters
Potential benefit: If successful, pre‑extubation dexamethasone could lower the risk of post‑extubation respiratory distress and shorten PICU stays for children on ventilators.
How similar studies have gone: Prior adult studies support pre‑extubation steroids for reducing airway obstruction; pediatric data are limited but suggest potential benefit, making this trial novel in children.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients intubated with an endotracheal tube with or without a cuff, * Aged from 2 days post-term to 6 years, * On mechanical ventilation for at least 36 hours, And meeting the following extubation criteria: * Extubation planned by the medical team * Fraction of inspired oxygen (FiO2) ≤ 45%, * Oxygen saturation measured by pulse oximeter ≥ 95% or appropriate according to the pathology, * Positive end-expiratory pressure (PEEP) ≤ 8 cmH2O, * Peak inspiratory pressure ≤ 22 cmH2O or presence of cough. * Affiliated with a social security system, * Collection of informed consent from the parental authority, by both parents or the legal guardian(s). Exclusion Criteria: * Refusal of consent by at least one parent or by the legal guardian(s), * Patient with a contraindication to IV-DXM: * Uncontrolled local or general infection, * Active viral infections (hepatitis, herpes, chickenpox, shingles), * Live vaccines, * Severe coagulation disorders, * Ongoing gastrointestinal bleeding, * Known hypersensitivity to IV-DXM or one of its excipients. * Patient participating in another interventional study involving human subjects or being in the exclusion period following a previous study involving human subjects, if applicable, * Patient receiving State Medical Aid, * Patient on long-term NIV, * Known upper airway pathology (UAP) before intubation or at the time of extubation, * History of UAP surgery within the month preceding inclusion, * Any situation deemed incompatible with the child's participation in the trial at the discretion of the investigating physician, * Decision to limit or stop therapeutic interventions. * Premature patients aged less than 40 weeks of gestation * Newborns aged less than 2 days after post-term birth
Where it's running
-
CHU Bordeaux - GH Pellegrin
Bordeaux, France Recruiting -
HFME Lyon-Bron
Bron, France Recruiting -
Hôpital Raymond Poincaré AP-HP
Garches, France Recruiting -
Hôpital Bicêtre AP-HP
Le Kremlin-Bicêtre, France Recruiting -
CHU Lille
Lille, France Recruiting -
La Timone AP-HM
Marseille, France Recruiting
Show 9 more locations
-
CHRU Nancy
Nancy, France Recruiting -
Hôpital Necker AP-HP
Paris, France Recruiting -
Hôpital Necker
Paris, France Recruiting -
Hôpital Necker
Paris, France Recruiting -
Hôpital Robert Debré AP-HP
Paris, France Recruiting -
Hôpital Trousseau AP-HP
Paris, France Recruiting -
Hôpital Haut-Lévêque CHU Bordeaux
Pessac, France Recruiting -
CHU Strasbourg Hautepierre
Strasbourg, France Recruiting -
CHRU de Tours - Hôpital Clocheville
Tours, France Recruiting
Study contacts
- Study coordinator: Stéphane Dauger, MD PhD
- Email: stephane.dauger@aphp.fr
- Phone: 140032187
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Experiences of Siblings of Children in Pediatric Intensive Care
This study looks at how having a brother or sister in the pediatric intensive care unit affects the feelings and experiences of siblings aged 10 to 18 years.
-
Music therapy during pediatric extubation.
See if adding music therapy during extubation helps stabilize vital signs and heart rate variability in children coming off mechanical ventilation.
-
Diffusion MRI to map nerve lesions in obstetric brachial plexus palsy
This study tests diffusion MRI and tractography to better understand nerve injuries in people with obstetric brachial plexus palsy.
-
Long-term心理 and cognitive check after stem cell transplant for immune deficiencies
This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
-
Gut microbes and autoinflammatory diseases: how they may be linked
This study tests whether gut bacteria and their byproducts relate to digestive and inflammatory symptoms in people with autoinflammatory diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.